The Pharma Times.in – August Issue

0
1151

Contents

http://emag.thepharmatimes.in/Login.aspx 

  • AIIMS in all States in a Phased Manner

The Minister of Health and Family Welfare, Dr. Harsh Vardhan stated that the Government has plans to consider setting up of AIIMS in each State in a phased manner.

The Ministry of Health and Family Welfare has requested the Chief Ministers of Andhra Pradesh, Arunachal Pradesh, Assam, Goa, Gujarat, Haryana, Himachal Pradesh, Jharkhand, Karnataka, Kerala, Maharashtra, Punjab and Tamil Nadu to identify suitable locations which could be examined for setting up of AIIMS, he stated.

  • Jaypee enters Healthcare Sector

Jaypee Hospital, the flagship hospital of the Jaypee Group has been planned and designed as a 1200 bedded tertiary care multi-super-specialty facility.

  • Cambridge varsity honour for Cipla chief

It was a very emotional moment. It brought back memories of my days as a student. I was an alumnus of Christ’s College, University of Cambridge in Cambridge from 1954 to 1960. It was where I studied chemistry. The drive to achieve excellence in chemistry was born there.

  • Entrepreneurship is our Passion “On the Right Track……”

Yes! We do read and come across various success stories of entrepreneurs and want to follow them.

We had a dream, a vision of being “The successful entrepreneurs”

Our dream of being successful entrepreneurs came into existence and we made it our passion.

The first thing that strikes a person’s mind while starting a business is, “Will it be a success or a failure?” and We believe that one must always be prepared for both.
– Dr. Devesh Kumar and Mr. Sushant Tyagi

  • BGS Global Hospitals Performs the 1st Dual Organ Transplantation in Karnataka

The dual organ transplantation was performed by a team multi organ transplant surgeons,

Dr. Mathew Jacob, Dr. Sonal Asthana, Dr. Rajiv Lochan & clinically supported by Dr. Kaiser Raja, Consultant, Hepatalogist, Dr. Anil Kumar, Consultant, Nephrologist, at BGS Global Hospitals.

  • Medical colleges in India – A review

MCI had recommended for disapproval of 118 medical colleges for renewal of permission for admission in 8567 MBBS seats for the academic session 2014-15. The Ministry has forwarded the compliance reports submitted by the concerned medical colleges to MCI for review and the same were placed before the Executive Committee of the Council at the meeting held on July 08th 2014 and July 12th 2014.

  • Establishment of New Medical Colleges Attached with District/Referral Colleges

The ratio of teachers to students has been revised depending on disciplines and availability of faculty to increase the number of specialists in the country. Land requirement for setting up of medical colleges has been relaxed from 25 acres to 20 acres throughout the country. Requirement of infrastructure like institution block, library, auditorium, examination hall, lecture theatres, etc. has been rationalized for optimal use.

  • Upgradation of Medical Colleges

The Government has approved upgradation of 39 existing Government Medical Colleges (including Karnataka Institute of Medical Sciences, Hubli) in the third phase of PMSSY, at an approved cost of Rs.150 Crore (Central contribution-Rs.120 Crore and State share- Rs.30 Crore) per Institute.

  • Multi-Disciplinary Research Units (MRUs) in Government Medical Colleges

The Department of Health Research has released grants to 29 Govt. medical colleges for the establishment of Multi-disciplinary Research Units (MRUs) during the year 2013-14, including 4 medical colleges in Tamil Nadu. List of medical colleges approved during 2013-14 for establishment of MRUs.

  • Plenary Session of the 67th World Health Assembly concludes in Geneva

In India “Health” has been given a central position in the national plan, running from 2012 to 2017. India has been successful in achieving remarkable reductions in Maternal Mortality Rate, Infant Mortality Rate, Neo-Natal Mortality Rate and the Total Fertility Rate, following strategic investments made under the National Rural Health Mission.

  • 100 percent immunization of children in select districts

The Union Health Minister Harsh Vardhan has ordered all stops be removed for 100 percent immunization of children in select districts of the states affected by annual visitations of two deadly strains of Encephalitis. The impulse has come from the death of 44 children in six districts of Bihar but the Minister is concerned over the annual death toll in adjoining eastern Uttar Pradesh as well which is in the 500-600 range.

  • HCG’s new standard-of-care for cancer treatment in India

HCG partners with Strand Life Sciences to integrate genomics as a ‘standard of care’ in cancer treatment and risk prediction. Cancer treatment adapted for Indian genomic variations. Affordable tests that improve precision treatment decisions and clinical outcomes in cancer care.

  • Around 19 Crore Indians likely to suffer from Skin Diseases by 2015

Skin disorders are among the most common diseases in school children in both developing and industrialized countries.

  • Kiran Mazumdar – Shaw Awarded the ‘2014 Global Economy Prize’

This annual prize is awarded to three individuals: A high ranking policy maker, a renowned economist and an outstanding entrepreneur.

  • Rise in Cancer Cases

As per data provided by National Cancer Registry Programme of Indian Council of Medical Research (ICMR), the number of persons diagnosed with cancer every year is increasing in our country.

  • Regulatory Mechanism for Private Hospitals

Government has enacted Clinical Establishments (Registration and Regulation) Act 2010 and notified Clinical Establishments Rules 2012 for registration and regulation of the Clinical Establishments including private hospitals. The States/UTs are required to adopt the Clinical Establishments (Registration and Regulation) Act 2010 under Article 252 of the Constitution.

  • Apollo Hospitals Announces Reorganization to Drive Next Wave of Growth

As the healthcare landscape in the country and the region changes and expands, this strategic realignment, will enable Apollo to focus on growth opportunities in hospitals, pharmacies, clinics and health insurance.

  • Intas Reinforces Fight Against MDS and AML Types of Cancer by Launching Azadine, for the First Time in India

Currently, for combating this type of cancer in the country, oncologists have to rely on an imported version of Azacitidine. The treatment cost of imported Azacitidine can range anywhere between Rs.15 to 18 lakh. The cost of treatment with other options, ranging from conventional agents to transplants, is estimated to cost between Rs.2 to 15 lakh.

http://emag.thepharmatimes.in/Login.aspx